Search results
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 2 days agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
All Over the Map? Mechanisms of ICI Acquired Resistance in NSCLC
MedPage Today· 7 days ago"Resistance is futile." What's less debatable, though, is that patients with non-small cell lung...
Plozasiran Paves RNA Interference Path to Triglyceride Reduction
MedPage Today· 3 days agoThe liver APOC3-targeted RNA interference agent plozasiran proved its triglyceride-lowering effects...
Genomic sequencing company expands manufacturing facility - Silicon Valley Business Journal
The Business Journals· 3 days agoThe facility represents the company’s inaugural U.S. supply chain, translating into faster delivery...
Association of Cancer Care Centers Announces Virtual Roadmap to Support EHR Integration for...
WKBN 27 Youngstown· 18 hours agoThe Association of Cancer Care Centers (ACCC) and LUNGevity today announced the launch of the Electronic Health Records (EHR) Integrations for Biomarker Testing: Roadmap, a new virtual resource ...
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday - San Francisco...
The Business Journals· 6 days agoShares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Alto...
Introducing peanut butter during infancy can help protect against a peanut allergy later on, new...
CNN.com· 3 days agoReassuring new evidence suggests that feeding children smooth peanut butter during infancy and early...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
CBS 47 Fresno· 7 days agoUSA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly ...
Johnson & Johnson Data Breach Reported; Possibly Connected to Major Lash Group Data Breach | JD...
JD Supra· 2 days agoOn May 29, 2024, Johnson & Johnson (“JNJ”) filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been provided to the company ...